Funding

CREATE Medicines

United States · Biotech · Healthtech

Develops in vivo immune programming platform for scalable, repeat-dose immunotherapies

Visit createmedicines.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series B$122MAlexandria Venture Investments — Role not disclosedARCH Venture Partners — Role not disclosedHatteras Venture Partners — Role not disclosedNewpath Partners — Role not disclosed

Investors

Alexandria Venture InvestmentsSeries BARCH Venture PartnersSeries BHatteras Venture PartnersSeries BNewpath PartnersSeries B

Coverage

May 14, 2026CREATE Medicines · Series B

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
Sourcescreatemedicines.com ↗